Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schachter

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Molecular Endocrinology (Baltimore, Md.)|September 1, 1988
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumorsT Garcia, S Lehrer, W D Bloomer, et al.
Biochimica Et Biophysica Acta|October 24, 1996
Synergistic activation of protein kinase C by arachidonic acid and diacylglycerols in vitro: generation of a stable membrane-bound, cofactor-independent state of protein kinase C activityJ B Schachter, D S Lester, D L Alkon
Molecular Endocrinology (Baltimore, Md.)|February 12, 1998
Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformationI Erenburg, B Schachter, R Mira y Lopez, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responsesQ Li, J B Schachter, T K Harden, et al.
Journal of Andrology|November 1, 1994
Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonistA Kirschenbaum, M Ren, I Erenburg, et al.
Neuropharmacology|November 19, 1997
HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptorsJ B Schachter, S M Sromek, R A Nicholas, et al.
Current Topics in Medicinal Chemistry|April 23, 2002
Tau protein phosphorylation as a therapeutic target in Alzheimer's diseaseLit-Fui Lau, Joel B Schachter, Patricia A Seymour, et al.
Molecular Pharmacology|March 1, 1992
Competitive regulation of phospholipase C responses by cAMP and calciumJ B Schachter, J K Ivins, R N Pittman, et al.
Molecular Pharmacology|November 1, 1996
Identification of competitive antagonists of the P2Y1 receptorJ L Boyer, T Romero-Avila, J B Schachter, et al.
Journal of Molecular Neuroscience : MN|January 24, 2003
Cdk5 as a drug target for the treatment of Alzheimer's diseaseLit-Fui Lau, Patricia A Seymour, Mark A Sanner, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Molecular Endocrinology (Baltimore, Md.)|September 1, 1988
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumorsT Garcia, S Lehrer, W D Bloomer, et al.
Biochimica Et Biophysica Acta|October 24, 1996
Synergistic activation of protein kinase C by arachidonic acid and diacylglycerols in vitro: generation of a stable membrane-bound, cofactor-independent state of protein kinase C activityJ B Schachter, D S Lester, D L Alkon
Molecular Endocrinology (Baltimore, Md.)|February 12, 1998
Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformationI Erenburg, B Schachter, R Mira y Lopez, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responsesQ Li, J B Schachter, T K Harden, et al.
Journal of Andrology|November 1, 1994
Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonistA Kirschenbaum, M Ren, I Erenburg, et al.
Neuropharmacology|November 19, 1997
HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptorsJ B Schachter, S M Sromek, R A Nicholas, et al.
Current Topics in Medicinal Chemistry|April 23, 2002
Tau protein phosphorylation as a therapeutic target in Alzheimer's diseaseLit-Fui Lau, Joel B Schachter, Patricia A Seymour, et al.
Molecular Pharmacology|March 1, 1992
Competitive regulation of phospholipase C responses by cAMP and calciumJ B Schachter, J K Ivins, R N Pittman, et al.
Molecular Pharmacology|November 1, 1996
Identification of competitive antagonists of the P2Y1 receptorJ L Boyer, T Romero-Avila, J B Schachter, et al.
Journal of Molecular Neuroscience : MN|January 24, 2003
Cdk5 as a drug target for the treatment of Alzheimer's diseaseLit-Fui Lau, Patricia A Seymour, Mark A Sanner, et al.
Pageof 6